Balancing Innovation: India’s Views for Pharmaceuticals in the Efta Trade Deal
IIPRD
APRIL 2, 2024
vi] This is where governments use ‘compulsory licensing’ to ensure access to affordable drugs in public health emergencies and foster innovation, where patents and monopolies gained through it has prevailed. Particularly the European Union has continuously pushed for the inclusion of data exclusivity clauses in discussions for FTAs.
Let's personalize your content